Literature DB >> 1781887

Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?

E Somers1, B R DasGupta.   

Abstract

Clostridium botulinum produce the antigenically distinct 150 kD neurotoxin serotypes (e.g., A, B, C1, and E) and simultaneously proteins, A Hn+, B Hn+, C Hn+, and E Hn-, that have high, low, and no hemagglutinating activity. A Hn+ and B Hn+ are serologically cross-reactive. A Hn+, B Hn+, and C Hn+ found as large aggregates (900-220 kD) can be dissociated on SDS-PAGE into multiple subunits, the smallest for A Hn+, B Hn+ is 17 kD and 27 kD for C Hn+. The 116 kD E Hn- does not aggregate. We determined the sequences of 10-33 amino terminal residues of the 17, 21.5, 35, and 57 kD subunits of A Hn+ and B Hn+. Each of these subunits have unique sequences, indicating that the larger units studies are not homomers or heteromers of smaller units. The subunits of A Hn+ and B Hn+ of comparable size have striking sequence identity (e.g., 21.5 kD subunits from the two are identical and 57 kD subunits have 80% identity). In vitro proteolysis of 116 kD E Hn- with different proteases did not impart hemagglutinating activity to the fragments. The 116 kD E Hn- and one of its proteolytic fragments (87 kD) were partially sequenced. Sixty-two base pairs downstream from the termination codon of the cloned 33 kD subunit of C Hn+, there is an initiation codon followed by an open reading frame for at least 34 amino acid residues (Tsuzuki et al., 1990). The derived amino acid sequence of this open reading frame, we found, has 73-84% sequence identity with those of the 17 kD subunits of A Hn+ and B Hn+ and significant identity with the N-terminal of E Hn-. These highly conserved sequences show existence of genetic linkage among the Hn+ and Hn- proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1781887     DOI: 10.1007/bf01025256

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  32 in total

1.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  The lack of identity between hemagglutinin and the toxin of type A botulinal organism.

Authors:  C LAMANNA; J P LOWENTHAL
Journal:  J Bacteriol       Date:  1951-06       Impact factor: 3.490

3.  Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G.

Authors:  M W Eklund; F T Poysky; L M Mseitif; M S Strom
Journal:  Appl Environ Microbiol       Date:  1988-06       Impact factor: 4.792

4.  Observations on receptor specific proteins. II. Haemagglutination and haemagglutination-inhibition reactions of Clostridium botulinum types A, C, D and E haemagglutinins.

Authors:  P Balding; E R Gold; D A Boroff; T A Roberts
Journal:  Immunology       Date:  1973-11       Impact factor: 7.397

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A.

Authors:  B R Dasgupta; D A Boroff; E Rothstein
Journal:  Biochem Biophys Res Commun       Date:  1966-03-22       Impact factor: 3.575

7.  Purification and characterization of hemagglutinin of Clostridium botulinum type C strain Stockholm.

Authors:  N Suzuki; B Syuto; S Kubo
Journal:  Jpn J Vet Res       Date:  1986-10       Impact factor: 0.649

8.  Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.

Authors:  I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

9.  Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex.

Authors:  L J Moberg; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1978-05       Impact factor: 4.792

10.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more
  13 in total

1.  Expression and purification of neurotoxin-associated protein HA-33/A from Clostridium botulinum and evaluation of its antigenicity.

Authors:  Ali Sayadmanesh; Firouz Ebrahimi; Abbas Hajizade; Mosayeb Rostamian; Hani Keshavarz
Journal:  Iran Biomed J       Date:  2013

Review 2.  Botulinum neurotoxin - from laboratory to bedside.

Authors:  K A Foster; H Bigalke; K R Aoki
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

4.  Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species.

Authors:  F Chen; G M Kuziemko; R C Stevens
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Characterization of botulinum progenitor toxins by mass spectrometry.

Authors:  Harry B Hines; Frank Lebeda; Martha Hale; Ernst E Brueggemann
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

6.  Characterization of new formalin-detoxified botulinum neurotoxin toxoids.

Authors:  James E Keller
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

7.  Colony immunoblot assay of botulinal toxin.

Authors:  M C Goodnough; B Hammer; H Sugiyama; E A Johnson
Journal:  Appl Environ Microbiol       Date:  1993-07       Impact factor: 4.792

8.  Organization of the botulinum neurotoxin C1 gene and its associated non-toxic protein genes in Clostridium botulinum C 468.

Authors:  D Hauser; M W Eklund; P Boquet; M R Popoff
Journal:  Mol Gen Genet       Date:  1994-06-15

9.  Conserved structure of genes encoding components of botulinum neurotoxin complex M and the sequence of the gene coding for the nontoxic component in nonproteolytic Clostridium botulinum type F.

Authors:  A K East; M D Collins
Journal:  Curr Microbiol       Date:  1994-08       Impact factor: 2.188

10.  Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism.

Authors:  J A Giménez; M A Giménez; B R DasGupta
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.